News > Page 83

• 

  Enhancing Viral Readiness: FDA's Strategic Moves Against H5N1 Threats

  5/12/2024
• 

  Exploring the Oral Microbiome as a Marker for Gastric Cancer Detection

  5/12/2024
• 

  Extended Review Timeline for Moderna's RSV Vaccine by FDA

  5/12/2024
• 

  A Comparative Analysis of Ceftaroline versus Vancomycin in Managing Complex Skin Infections

  5/12/2024
• 

  New Frontiers in Cancer Treatment: FDA Greenlights WGc-043 mRNA Vaccine for Clinical Trials

  5/12/2024
• 

  U.S. Government Allocates Over $175 Million to Combat Avian Influenza Amid Low Public Risk

  5/12/2024
• 

  Exploring the Link Between mRNA COVID-19 Vaccines and Rare Thyroid Disorders

  5/11/2024
• 

  Exploring the Impact of Federal Funding Shifts on Cancer Research

  5/11/2024
• 

  Advancements in Bladder Cancer Treatment: Nivolumab and Nab-Paclitaxel Combination Proves Promising

  5/11/2024
• 

  Exploring Advanced Lung Cancer Treatment: New Insights from the CheckMate73L Trial

  5/11/2024